Annual Total Expenses
$192.11 M
+$16.48 M+9.38%
December 31, 2023
Summary
- As of February 25, 2025, ANIK annual total expenses is $192.11 million, with the most recent change of +$16.48 million (+9.38%) on December 31, 2023.
- During the last 3 years, ANIK annual total expenses has risen by +$47.19 million (+32.56%).
- ANIK annual total expenses is now at all-time high.
Performance
ANIK Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$63.67 M
+$21.91 M+52.46%
September 30, 2024
Summary
- As of February 25, 2025, ANIK quarterly total expenses is $63.67 million, with the most recent change of +$21.91 million (+52.46%) on September 30, 2024.
- Over the past year, ANIK quarterly total expenses has stayed the same.
- ANIK quarterly total expenses is now at all-time high.
Performance
ANIK Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
ANIK Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.4% | 0.0% |
| 3 y3 years | +32.6% | +52.7% |
| 5 y5 years | +129.2% | +260.8% |
ANIK Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +15.5% | at high | +58.2% |
| 5 y | 5-year | at high | +139.1% | at high | +155.0% |
| alltime | all time | at high | +4825.9% | at high | >+9999.0% |
Anika Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $63.67 M(+52.5%) |
| Jun 2024 | - | $41.76 M(-8.4%) |
| Mar 2024 | - | $45.59 M(+2.3%) |
| Dec 2023 | $192.11 M(+9.4%) | $44.56 M(-9.3%) |
| Sep 2023 | - | $49.14 M(+2.5%) |
| Jun 2023 | - | $47.93 M(-5.0%) |
| Mar 2023 | - | $50.48 M(+9.0%) |
| Dec 2022 | $175.64 M(+5.6%) | $46.29 M(+0.5%) |
| Sep 2022 | - | $46.06 M(+7.0%) |
| Jun 2022 | - | $43.04 M(+6.9%) |
| Mar 2022 | - | $40.25 M(-8.8%) |
| Dec 2021 | $166.27 M(+14.7%) | $44.12 M(+5.8%) |
| Sep 2021 | - | $41.69 M(-2.2%) |
| Jun 2021 | - | $42.62 M(+12.6%) |
| Mar 2021 | - | $37.85 M(-2.3%) |
| Dec 2020 | $144.93 M(+80.3%) | $38.76 M(+9.3%) |
| Sep 2020 | - | $35.47 M(-1.5%) |
| Jun 2020 | - | $36.02 M(+3.9%) |
| Mar 2020 | - | $34.68 M(+38.9%) |
| Dec 2019 | $80.36 M(-4.1%) | $24.97 M(+41.5%) |
| Sep 2019 | - | $17.65 M(-4.6%) |
| Jun 2019 | - | $18.50 M(-3.8%) |
| Mar 2019 | - | $19.24 M(+11.9%) |
| Dec 2018 | $83.81 M(+23.8%) | $17.19 M(-5.6%) |
| Sep 2018 | - | $18.21 M(-5.6%) |
| Jun 2018 | - | $19.30 M(-33.7%) |
| Mar 2018 | - | $29.10 M(+48.0%) |
| Dec 2017 | $67.69 M(+28.3%) | $19.66 M(+16.2%) |
| Sep 2017 | - | $16.91 M(+7.5%) |
| Jun 2017 | - | $15.74 M(+2.3%) |
| Mar 2017 | - | $15.38 M(-3.8%) |
| Dec 2016 | $52.77 M(+17.6%) | $15.99 M(+32.1%) |
| Sep 2016 | - | $12.10 M(-7.7%) |
| Jun 2016 | - | $13.11 M(+13.3%) |
| Mar 2016 | - | $11.57 M(-16.3%) |
| Dec 2015 | $44.87 M(+1.6%) | $13.83 M(+31.1%) |
| Sep 2015 | - | $10.55 M(+0.7%) |
| Jun 2015 | - | $10.47 M(+4.6%) |
| Mar 2015 | - | $10.02 M(-10.3%) |
| Dec 2014 | $44.15 M(+3.2%) | $11.17 M(-5.1%) |
| Sep 2014 | - | $11.77 M(+6.3%) |
| Jun 2014 | - | $11.07 M(+9.2%) |
| Mar 2014 | - | $10.14 M(-4.9%) |
| Dec 2013 | $42.76 M(-12.9%) | $10.66 M(+4.7%) |
| Sep 2013 | - | $10.18 M(-11.8%) |
| Jun 2013 | - | $11.54 M(+11.3%) |
| Mar 2013 | - | $10.37 M(-15.5%) |
| Dec 2012 | $49.11 M(-3.4%) | $12.28 M(+2.0%) |
| Sep 2012 | - | $12.04 M(-10.8%) |
| Jun 2012 | - | $13.49 M(+19.4%) |
| Mar 2012 | - | $11.30 M(-16.5%) |
| Dec 2011 | $50.81 M(+5.8%) | $13.53 M(-0.8%) |
| Sep 2011 | - | $13.64 M(+9.4%) |
| Jun 2011 | - | $12.46 M(+11.5%) |
| Mar 2011 | - | $11.18 M(-8.7%) |
| Dec 2010 | $48.02 M(+48.2%) | $12.24 M(+3.8%) |
| Sep 2010 | - | $11.79 M(-7.1%) |
| Jun 2010 | - | $12.70 M(+12.5%) |
| Mar 2010 | - | $11.29 M(+64.5%) |
| Dec 2009 | $32.40 M(+2.7%) | $6.86 M(-21.8%) |
| Sep 2009 | - | $8.78 M(+5.5%) |
| Jun 2009 | - | $8.32 M(-1.5%) |
| Mar 2009 | - | $8.44 M(+9.4%) |
| Dec 2008 | $31.55 M | $7.72 M(-2.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2008 | - | $7.87 M(-3.6%) |
| Jun 2008 | - | $8.17 M(+4.8%) |
| Mar 2008 | - | $7.79 M(+3.8%) |
| Dec 2007 | $24.24 M(+13.2%) | $7.51 M(+23.4%) |
| Sep 2007 | - | $6.09 M(+6.1%) |
| Jun 2007 | - | $5.74 M(+16.7%) |
| Mar 2007 | - | $4.92 M(-2.1%) |
| Dec 2006 | $21.41 M(+0.6%) | $5.02 M(+11.9%) |
| Sep 2006 | - | $4.48 M(-25.2%) |
| Jun 2006 | - | $6.00 M(+1.4%) |
| Mar 2006 | - | $5.91 M(+28.3%) |
| Dec 2005 | $21.28 M(+6.0%) | $4.61 M(-24.9%) |
| Sep 2005 | - | $6.14 M(+21.5%) |
| Jun 2005 | - | $5.05 M(-7.9%) |
| Mar 2005 | - | $5.49 M(+4.0%) |
| Dec 2004 | $20.08 M(+35.6%) | $5.27 M(+7.7%) |
| Sep 2004 | - | $4.90 M(-1.6%) |
| Jun 2004 | - | $4.97 M(+0.8%) |
| Mar 2004 | - | $4.94 M(+18.1%) |
| Dec 2003 | $14.81 M(-10.0%) | $4.18 M(+26.8%) |
| Sep 2003 | - | $3.30 M(-4.1%) |
| Jun 2003 | - | $3.44 M(-11.7%) |
| Mar 2003 | - | $3.89 M(+5.5%) |
| Dec 2002 | $16.46 M(-12.1%) | $3.69 M(-4.7%) |
| Sep 2002 | - | $3.87 M(-16.5%) |
| Jun 2002 | - | $4.64 M(+9.0%) |
| Mar 2002 | - | $4.26 M(+15.1%) |
| Dec 2001 | $18.72 M(+8.1%) | $3.70 M(-17.5%) |
| Sep 2001 | - | $4.48 M(-22.4%) |
| Jun 2001 | - | $5.78 M(+27.1%) |
| Mar 2001 | - | $4.55 M(-9.8%) |
| Dec 2000 | $17.32 M(+25.1%) | $5.04 M(+14.2%) |
| Sep 2000 | - | $4.41 M(+2.5%) |
| Jun 2000 | - | $4.31 M(+21.5%) |
| Mar 2000 | - | $3.55 M(+5.9%) |
| Dec 1999 | $13.85 M(+29.4%) | $3.35 M(-9.5%) |
| Sep 1999 | - | $3.70 M(+2.8%) |
| Jun 1999 | - | $3.60 M(+12.5%) |
| Mar 1999 | - | $3.20 M(+10.3%) |
| Dec 1998 | $10.70 M(+21.6%) | $2.90 M(+3.6%) |
| Sep 1998 | - | $2.80 M(+3.7%) |
| Jun 1998 | - | $2.70 M(+17.4%) |
| Mar 1998 | - | $2.30 M(-23.3%) |
| Dec 1997 | $8.80 M(+125.6%) | $3.00 M(+66.7%) |
| Sep 1997 | - | $1.80 M(-14.3%) |
| Jun 1997 | - | $2.10 M(+23.5%) |
| Mar 1997 | - | $1.70 M(-19.0%) |
| Dec 1996 | $3.90 M(-48.7%) | - |
| Nov 1996 | - | $2.10 M(-4.5%) |
| Aug 1996 | - | $2.20 M(0.0%) |
| Aug 1996 | $7.60 M(+43.4%) | - |
| May 1996 | - | $2.20 M(+4.8%) |
| Feb 1996 | - | $2.10 M(+50.0%) |
| Nov 1995 | - | $1.40 M(-17.6%) |
| Aug 1995 | $5.30 M(-13.1%) | $1.70 M(+21.4%) |
| May 1995 | - | $1.40 M(+55.6%) |
| Feb 1995 | - | $900.00 K(-35.7%) |
| Nov 1994 | - | $1.40 M(-6.7%) |
| Aug 1994 | $6.10 M(+48.8%) | $1.50 M(-6.3%) |
| May 1994 | - | $1.60 M(0.0%) |
| Feb 1994 | - | $1.60 M(+14.3%) |
| Nov 1993 | - | $1.40 M(-50.0%) |
| Aug 1993 | $4.10 M | $2.80 M(+460.0%) |
| May 1993 | - | $500.00 K |
FAQ
- What is Anika Therapeutics annual total expenses?
- What is the all time high annual total expenses for Anika Therapeutics?
- What is Anika Therapeutics annual total expenses year-on-year change?
- What is Anika Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Anika Therapeutics?
- What is Anika Therapeutics quarterly total expenses year-on-year change?
What is Anika Therapeutics annual total expenses?
The current annual total expenses of ANIK is $192.11 M
What is the all time high annual total expenses for Anika Therapeutics?
Anika Therapeutics all-time high annual total expenses is $192.11 M
What is Anika Therapeutics annual total expenses year-on-year change?
Over the past year, ANIK annual total expenses has changed by +$16.48 M (+9.38%)
What is Anika Therapeutics quarterly total expenses?
The current quarterly total expenses of ANIK is $63.67 M
What is the all time high quarterly total expenses for Anika Therapeutics?
Anika Therapeutics all-time high quarterly total expenses is $63.67 M
What is Anika Therapeutics quarterly total expenses year-on-year change?
Over the past year, ANIK quarterly total expenses has changed by $0.00 (0.00%)